L M Xing Selected Research

Iron

2/2024

[Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L M Xing Research Topics

Disease

4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2024 - 04/2016
2	Aplastic Anemia (Anemia, Hypoplastic) 11/2021 - 05/2014
1	Hemorrhage 03/2024
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 02/2024
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 09/2018
1	Pathologic Complete Response 04/2017

Drug/Important Bio-Agent (IBA)

4	Inosine Triphosphate (ITP)IBA 03/2024 - 04/2016
1	eltrombopag FDA Link 03/2024
1	ferric derisomaltoseIBA 02/2024
1	Saccharated Ferric Oxide (Venofer)FDA Link 02/2024
1	Hemoglobins (Hemoglobin)IBA 02/2024
1	IronIBA 02/2024
1	HLA-A Antigens (HLA-A)IBA 11/2021
1	Complement System Proteins (Complement)IBA 09/2018
1	CytokinesIBA 05/2017
1	NK Cell Lectin-Like Receptor Subfamily CIBA 04/2017
1	Natural Cytotoxicity Triggering Receptor 2IBA 04/2017
1	Fas Ligand Protein (Fas Ligand)IBA 05/2014

Therapy/Procedure

1	Aftercare (After-Treatment) 02/2024
1	Intravenous Infusions 02/2024